Status:
COMPLETED
A Retrospective, Observational Chart Review of Biologics in Monotherapy Versus the Combination Biologic Plus Methotrexate in Patients With Rheumatoid Arthritis
Lead Sponsor:
Hoffmann-La Roche
Conditions:
Rheumatoid Arthritis
Eligibility:
All Genders
18+ years
Brief Summary
This cross-sectional, non-interventional, retrospective chart review will compare the efficacy and safety of biologic monotherapy and biologic and methotrexate combination therapy in patients with rhe...
Eligibility Criteria
Inclusion
- Adult patients, \>/= 18 years of age
- Diagnosis of rheumatoid arthritis by a rheumatologist
- Patients who have responded inadequately to methotrexate or disease-modifying anti-rheumatic drugs (DMARDs) and are being prescribed a biologic in monotherapy or in combination with methotrexate and other classical DMARDs as per NICE guidelines
Exclusion
- Primary diagnosis of a condition other than rheumatoid arthritis
- Current treatment with a biologic in combination without methotrexate
- Prior treatment with an experimental agent for rheumatoid arthritis
Key Trial Info
Start Date :
April 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2014
Estimated Enrollment :
476 Patients enrolled
Trial Details
Trial ID
NCT01866150
Start Date
April 1 2013
End Date
March 1 2014
Last Update
October 5 2015
Active Locations (15)
Enter a location and click search to find clinical trials sorted by distance.
1
Cambridge, United Kingdom, CB2 0QQ
2
Chelmsford, United Kingdom, CM1 7ET
3
Cosham, United Kingdom, PO6 3LY
4
Derby, United Kingdom, DE22 3NE